
​Fred Massoomi, PharmD, discusses compounding options.

Petrea Cober, PharmD, BCNSP, BCPPS, discusses the challenges of parenteral nutrition education.

Arching Shrestha, MD, discusses the challenges of treating epilepsy in the elderly.

Sanjeev V. Thomas, MD, DM, FANA—professor of neurology, chairman of the Epilepsy Program, Sree Chitra Tirunal Institute—discusses why the risk of seizures is higher for women during the peripartum period.

Jacqueline A. French, MD—professor of neurology, NYU Comprehensive Epilepsy Study Consortium, president, The Epilepsy Study Consortium—discusses how the new ILAE definition of epilepsy and classification of seizures differ from the previous versions.

Antibiotic resistance has become one of the most serious emerging threats to public health.

Antiepileptic drugs and seizures may harm a fetus, so it is important for physicians to plan an individualized treatment strategy for women with epilepsy.

Intradepartmental hospital pharmacy groups can play a key role in helping to identify and troubleshoot problem areas.

Collaboration between physicians, patients, and pharmacists is essential to address the public health crisis of opioid misuse and overdose in the United States.

Intradepartmental hospital pharmacy groups can play a key role in helping to identify and troubleshoot problem areas, according to a presentation at the ASHP Midyear 2016 Clinical Meeting and Exhibition.

Collaboration between physicians, patients, and pharmacists is essential for addressing the public health crisis of opioid misuse and overdose in the United States, according to a presentation at the ASHP Midyear 2016 Clinical Meeting and Exhibition.

Christopher M. Jones, PharmD, CDR, US Public Health Service, discusses opportunities for pharmacists to reduce opioid prescription rates.

Jacqueline A. French, MD—professor of neurology, NYU Comprehensive Epilepsy Study Consortium, president, The Epilepsy Study Consortium—discusses how the new ILAE definition of epilepsy may change the disease.

Elizabeth Thiele, MD, PhD, pediatric neurologist/epileptologist, discusses treatment options for patients with epilepsy due to tuberous sclerosis complex.

Elizabeth Thiele, MD, PhD, pediatric neurologist/epileptologist, discusses the impact of tuberous sclerosis complex on children.

Jacqueline A. French, MD—professor of neurology, NYU Comprehensive Epilepsy Study Consortium, president, The Epilepsy Study Consortium—discusses how the new ILAE definition of epilepsy can improve patient outcomes.

Not planning pregnancy in women with epilepsy could lead to fetal malformations.

Elizabeth Thiele, MD, PhD, pediatric neurologist/epileptologist, discusses symptoms of tuberous sclerosis complex and the role early detection plays in disease prognosis.

For the first time, the new International League Against Epilepsy (ILAE) seizure classifications were presented at the American Epilepsy Society conference during the Annual Fundamentals Symposium: The New Definition and Classification of Epilepsy on Friday, December 2, 2016.

The definition of epilepsy has been updated by the International League Against Epilepsy.

Speakers discuss the state of epilepsy care around the world at the AES conference.

Elizabeth Thiele, MD, PhD--pediatric neurologist/epileptologist, director, The Carol and James Herscot Center for Children and Adults with TSC, Massachusetts General Hospital--discusses tuberous sclerosis complex.

The report examines changing areas that will impact pharmacists.

Pharmacy teams from 6 institutes won the ASHP Best Practices Award.

ASHP’s 2016 Midyear Clinical Meeting is the largest gathering of clinical pharmacists in the world.

The holidays are just around the corner, but that’s not the only exciting thing about this time of year. ASHP’s 2016 Midyear Clinical Meeting is coming up, and Pharmacy Times is on site covering it.

Baricitinib significantly improved patient-reported outcomes in individuals with RA.

New drugs for psoriatic arthritis discussed during a session at the ACR/ARHP conference.

At the Annual Meeting of the American College of Rheumatology in Washington, DC, several experts presented their progress in harnessing technology to help teenagers and young adults manage their juvenile arthritis.

Study compares the safety and efficacy of sarilumab with adalimumab in patients who cannot tolerate methotrexate.